Glaukos Corporation (GKOS) Stock Overview
NYSE · Healthcare · Medical Devices
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Glaukos Corporation
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat…
Source: Yahoo Finance
Sector & Industry
Glaukos Corporation operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NYSE exchange.
Glaukos Corporation at a Glance
| Company | Glaukos Corporation |
| Ticker | GKOS |
| Exchange | NYSE |
| Currency | USD |
| Price | $177.47 |
| Market cap | $10.47B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$3.27 |
| 52-week high | $191.62 |
| 52-week low | $73.16 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.77 |
| Return on equity (ROE) | -25.98% |
| Debt-to-equity | 15.77% |
| Average volume | 817,041 |
| Shares outstanding | 58.98M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 1,094 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Glaukos Corporation's current P/E ratio?
- Glaukos Corporation (GKOS) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Glaukos Corporation's market capitalisation?
- Glaukos Corporation's market cap is $10.47B based on our latest snapshot. See how it ranks by market cap →
- What is GKOS's 52-week range?
- Over the past 52 weeks, GKOS has traded between $73.16 and $191.62. What does the 52-week range mean? →
- How volatile is Glaukos Corporation compared to the market?
- Glaukos Corporation has a beta of 0.77, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Glaukos Corporation pay a dividend?
- Glaukos Corporation does not currently pay a dividend according to our latest data.
- What exchange is GKOS listed on?
- GKOS is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Glaukos Corporation in?
- Glaukos Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →